Table 1. Body weight during postnatal development and between treatment groups.

Drug	E18	P3	P20	Adult
				Male	female
Saline	1.21±0.11 (n = 36)	1.96±0.22 (n = 32)	8.40±0.97 (n = 32)	30.35±1.96 (n = 15)	22.34±0.95 (n = 17)
Fluvoxamine	1.15±0.09 (n = 37)	1.96±0.20 (n = 34)	8.21±0.83 (n = 34)	29.88±1.33 (n = 18)	22.00±0.80 (n = 16)
Fluoxetine	1.23±0.11 (n = 33)	1.93±0.12 (n = 26)	8.45±0.84 (n = 6)	30.88±1.93 (n = 4)	23.14±0.47 (n = 2)